Which ETFs own IMAB?
NOVABRIDGE BIOSCIENCES ADR — 5 ETFs hold it, worth $2.4M across 713.97K shares.
Holdings as of Aug 26, 2026 — portfolio reporting dates from the data provider; not live positions.
| # | ETF | Weight | Shares | Value | ETF AUM | Category | Today | |
|---|---|---|---|---|---|---|---|---|
| 1 | CNCR Loncar Cancer Immunotherapy ETF | 3.25% | 21.30K | $872.2K | $12.7M | Biotech | +1.58% | |
| 2 | CHNA Loncar China BioPharma ETF | 1.65% | 4.26K | $164.4K | $10.0M | Biotech | -0.07% | |
| 3 | QQQS Invesco NASDAQ Future Gen 200 ETF | 0.51% | 60.77K | $116.1K | $23.1M | Healthcare | -0.06% | |
| 4 | IBBQ Invesco Nasdaq Biotechnology ETF | 0.01% | 6.55K | $12.5K | $95.8M | Biotech | -0.62% | |
| 5 | IBB iShares Biotechnology ETF | 0.01% | 621.09K | $1.2M | $10.84B | Biotech | -0.54% |
Coverage reflects the ETF portfolios loaded in our database; very small funds may not be swept yet. Market data delayed approximately 15–20 minutes unless otherwise indicated.